According to the first study, 47% (18/38) of subjects showed anti–GAD65 similar to primary T1DM [101], even if these and other autoantibodies are detectable before the clinical onset in more than 95% of patients with T1DM [116]. Here, GAD2 is linked to type 1 diabetes mellitus.